Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

NewsGuard 100/100 Score

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

According to the document, the government aims to reduce by half malaria-related deaths by 2010. The malaria control plan is in an effort to achieve the U.N. Millennium Development Goal of combating malaria, in addition to national health and development priorities.

Malaria control activities will involve a "broad partnership," including all sectors of society, various levels of the government, civil society organizations, traditional and religious leaders and the private sector, Xinhua reports. "Community involvement and empowerment will be a key cornerstone of this strategic plan,'' the document said.

The plan includes a monitoring and evaluation framework and highlights factors that lead to the spread of malaria (Xinhua, 6/1).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pioneering study launched to examine how the immune system responds to repeated malaria infections